Disclaimer

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.

US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.
Videos

Contemporary Treatment of Aortic Regurgitation

Aortic regurgitation is an undertreated condition, often because patients are not referred in a timely fashion for intervention. During this STS webinar, moderated by Dr. Gorav Ailawadi and Dr. Tsuyoshi Kaneko, attendees will hear from an expert panel on the evidence base for timing of intervention as well as evolving treatment options.

Latest News

View All
Press
JenaValve Announces Start of Commercialization of the Trilogy<sup>®</sup> Transcatheter Heart Valve System in the US
April 1, 2026
JenaValve Announces Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the US
Read More
Press
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System
March 18, 2026
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System
Read More
Press
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More
Close Download
Close Download
The JenaValve TrilogyTM Heart Valve System Billing Guide contains appropriate coding (e.g. CPT, ICD-10, and HCPCS), coverage, and payment for procedures performed with the JenaValve TrilogyTM Heart Valve System. For additional information, please contact us at reimbursement.usa@jenavalve.com.